摘要
目的：探讨前列腺癌（ Ｐ Ｃａ） 患者治疗前血清前列腺特异性抗原（ Ｐ Ｓ Ａ） 水平对评估 Ｐ Ｃａ 预后的价值。方法：采用放射免疫分析法检测２４ 例预后良好和３３ 例预后不良的 Ｐ Ｃａ 患者治疗前的血清 Ｐ Ｓ Ａ 水平。结果：两组病例治疗前血清 Ｐ Ｓ Ａ 水平显著高于正常对照组（ Ｐ＜ ０ ．０１） ， Ｐ Ｃａ 患者预后不良组治疗前血清 Ｐ Ｓ Ａ 水平亦显著高于预后良好组（ Ｐ＜ ０ ．０１） 。结论： Ｐ Ｃａ 患者治疗前血清 Ｐ Ｓ Ａ 水平对评估其预后具有一定价值。
Objective:To study the prognostic value of the serum levels of prostate specific antigen(PSA) before treatment.Methods:Radioimmunoassay(RIA) was used to measure the serum PSA levels of 57 patients with prostate cancer before treatment,among them the prognosis was poor in 33 and better in 24.Results:Before treatment,the serum PSA levels in two cancer groups were higher than that in control group( P <0.01).The serum PSA levels in bad prognosis group were significantly higher than those in better prognosis group( P < 0.01 ).Conclusions:Testing for serum PSA levels is valuable in judging the prognosis of prostate cancer before treatment .
出处
《蚌埠医学院学报》
CAS
1999年第6期484-485,共2页
Journal of Bengbu Medical College
关键词
前列腺肿瘤
特异性抗原
放射免疫测定
prostatic neoplasms
prostate specific antigen
radioimmunoassay
